Authors:
Guillaume, B
Ameye, G
Dierlamm, J
Verhoef, G
Duhem, C
Ferrant, A
Hagemeijer, A
Verellen-Dumoulin, C
Michaux, L
Citation: B. Guillaume et al., Trisomy 16 as the sole anomaly in hematological malignancies: three new cases and a short review, CANC GENET, 128(2), 2001, pp. 168-171
Authors:
Michaux, L
Wlodarska, I
Stul, M
Dierlamm, J
Mugneret, F
Herens, C
Beverloo, B
Verhest, A
Verellen-Dumoulin, C
Verhoef, G
Selleslag, M
Madoe, V
Lecomte, M
Deprijck, B
Ferrant, A
Delannoy, A
Marichal, S
Duhem, C
Dicato, M
Hagemeijer, A
Citation: L. Michaux et al., MLL amplification in myeloid leukemias: A study of 14 cases with multiple copies of 11q23, GENE CHROM, 29(1), 2000, pp. 40-47
Authors:
Cecchelli, R
Fenart, L
Buee-Scherrer, V
Dehouck, B
Descamps, L
Duhem, C
Torpier, G
Dehouck, MP
Citation: R. Cecchelli et al., In vitro models of the blood-brain barrier and their use in drug development, BLOOD-BRAIN BARRIER AND DRUG DELIVERY TO THE CNS, 2000, pp. 65-75
Authors:
Fenart, L
Casanova, A
Dehouck, B
Duhem, C
Slupek, S
Cecchelli, R
Betbeder, D
Citation: L. Fenart et al., Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier, J PHARM EXP, 291(3), 1999, pp. 1017-1022